Lipase - Altus Pharmaceuticals

Drug Profile

Lipase - Altus Pharmaceuticals

Alternative Names: TheraCLEC Lipase

Latest Information Update: 14 Oct 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Altus Pharmaceuticals
  • Class Carboxylic ester hydrolases
  • Mechanism of Action Lipase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pancreatic disorders

Most Recent Events

  • 16 Dec 2002 Discontinued - Preclinical for Pancreatic disorders in USA (PO)
  • 08 Dec 1998 Preclinical development for Pancreatic disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top